idexx remain top dog boost
updat forecast estim feb
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim feb
price data
rate updat
currenc amount express
valuat growth profit
methodolog valu compani
steadili increas scale reach
veterinari diagnost lab busi dig narrow moat
well-posit benefit two key trend first pet ownership
continu grow household own pet
compar furthermor pet owner
demonstr greater willing spend anim
tripl spend pet product servic
offer impress wide rang companion anim
diagnost test deliv mani form exampl carv
leadership posit single-us test kit in-offic use
conveni result minut mani routin
recur diagnost switch outsid lab kit idexx
also maintain strong posit off-sit lab test anoth area
histor seen double-digit growth final enjoy
leadership posit in-hospit instrument focu
develop broaden menu test make
one-stop shop anim hospit uniqu abl
cross-sel mani product servic develop
strong sale organ provid tailor solut
abil sniff opportun build better mousetrap
cross smaller water-test production-animal-test
busi municip often requir routin test
water suppli offer uniqu test detect two
common bacteri contamin easier faster
use tradit test method allow firm
captur water market also
leader livestock poultri diagnost includ test
foot-and-mouth diseas although segment seen
growth robust pet busi gener offer
fatter margin anticip mani year growth ahead
rise incom emerg market feed appetit anim
protein like innov demonstr
expect come
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
idexx laboratori primarili develop manufactur distribut
diagnost product equip servic pet livestock key
product line includ single-us canin felin test kit veterinarian
employ offic laboratori equip blood-panel analysi
refer lab servic test detect manag diseas livestock
get revenu outsid unit state
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
idexx remain top dog pet diagnost
idexx lab deliv anoth strong quarter wrap
stellar year featur organ growth companion
anim segment substanti boost fair valu
estim per share roughli half
increas driven optimist project
companion anim busi
half fed lower-than-expect new tax rate idexx
come corpor tax cut remain fan idexx
narrow econom moat root cost advantag
intang asset stand behind posit moat
trend rate firm begun build initi network
effect test softwar allow vet
practic understand perform
even without favor tailwind foreign exchang
organ quarterli revenu growth left us impress
consist exce market growth thank
innov coupl high level execut think
recent invest made beef salesforc
bring increas return result
weve bake optimist project next three
year companion anim busi particular
strong placement growth instrument includ catalyst
sedivu key engin on-going stream
increas instal catalyst base
forecast robust mid-teen growth vetlab consum
also expect slight uptick placement
diagnost analyz by-product corpor tax
cut mani vet practic s-corpor enjoy
new effect tax rate anticip
practic invest windfal premium analyz
per share incorpor lower-than-expect
new effect tax rate along optimist
project companion anim busi
period thank favor macroeconom
condit major gain instal base analyz
expect robust growth vetlab consum
vet get board in-hous test also expect
double-digit growth refer lab segment
ad new rout open possibl
increas densiti rout medium term thu
bullish two largest fastest-grow
product line companion anim segment boost
all-direct sale model aggress placement
instrument project averag consum
growth also estim
refer lab growth averag per year
begun reap benefit new sale format
focus smaller territori custom contact
nurtur closer relationship vet think
growth sustain bar major pullback
economi consid opportun cross-sel
on-going progress penetr new anim
hospit analyz instrument believ
plenti potenti sale consult sell new
servic develop stickier relationship
meantim continu roll new product
recept companion anim practic expect
averag annual growth companion anim segment
primarili fed adopt seri
new product larger base analyz sale ancillari
servic grow strength consum
refer lab consid adopt curv
in-hous diagnost equip tend slow steadi
sever year reap reward
string new product launch deck
valuat growth profit feb
substanti rais fair valu estim
nonetheless even increas valuat share look
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
hand companion-anim segment growth
hover rang firm slip cost control
key rapid assay kit succumb competit bring
fair valu estim per share
leader point-of-car diagnost test
in-hous analyz equip hold well-establish
posit refer lab duopoli vca soon
acquir privat held mar econom moat
driven sever sourc first firm reli intellectu
properti protect know-how goe
diagnost test key competit advantag
abil consist innov diagnost test firm
come new gener test assay
laboratori equip test diseas
human product anim water test well
companion anim product servic
typic focu test new type diseas
parasit improv turnaround time test result
increas accuraci result enhanc
conveni on-sit test firm also offer
integr vet practic manag softwar packag
simplifi transmiss test data patient medic
second moat bolster switch cost across
number product exampl
cornerston practic manag softwar
anim hospit staff invest time enter
patient client inform becom familiar
softwar inconveni instal learn
whole new system mean custom tend stick
principl appli in-hous test
equip practic instal base
equip train vet tech practic
like stick switch anoth brand
overpr us current price around per share impli
would need consist deliv annual
top-lin growth approxim basi point excess
quickli companion anim healthcar market
grown histor time recent runup share
suggest investor anticip could purchas
premium rival vca mar
base larg averag volatil cash flow
divers product portfolio rate uncertainti
base case assum abl expand
busi ahead market
adopt new product strong refer lab
perform drive top-lin growth aid
eas consum discretionari spend
upsid growth companion-anim segment
reach histor mid-double-digit level next
five year -- outpac market roughli basi point
annual --
manufactur effici
attain hike fair valu estim per share
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
custom switch cost also rise vet practic
purchas multipl product servic
exampl custom retent notic higher
practic combin refer lab in-hous
analyz softwar integr
final also enjoy cost advantag
diagnost lab extens scale larg
nation lab network abl run test lower
cost thank higher throughput volum ensu
effici use lab result attract margin
smaller-scal independ lab offer
rival vca antech creat duopoli market
built rout network dens
effici element contribut
moat render price tertiari factor
gain scale allow make serial
acquisit new competitor might emerg
seriou threat recent solidifi
posit production-anim segment europ
enter biomed clinic test market
acquisit radil acquir distributor brazil
sanofi bayer
see moat trend posit sever reason
production-anim diagnost market popul
group smaller pure-play compani pharmaceut
commercial-anim diagnost tini contributor
larger busi think unlik larg pharma
competitor focu much attent market
often seek much bigger profit fish fri
hand small pure play like advanc anim
diagnost could appeal purchas
companion-anim refer lab segment vca
part mar primarili split domest market
special type lab test continu conduct
anim hospit lab associ veterinari school
major bread-and-butt test handl
within duopoli human refer laboratori giant
dip toe anim diagnost
market one refer lab east coast quest
sinc refocus new opportun human diagnost
anim diagnost impress record
introduc innov thank robust spend
account estim spend
anim diagnost market made
attract partner pharmaceut firm would like
market therapi along companion
diagnost exampl boehring ingelheim team
market vetmedin treat congest heart failur
dog along cardiopet probnp test
provid earli detect heart failur anim medicin
continu move path pair therapi
diagnost expect highli sought
equip though diagnost test sent
refer lab result within follow two
day turnaround in-hous equip faster
conveni vet practic trade anim
hospit higher-margin in-hous test reap
financi reward even diagnost test
divert refer lab note
make steadi progress persuad practic use
competit in-hous analyz switch idexx
equip grow base instal unit bode well
continu stream consum revenu
final think bold decis institut all-direct
distribut instrument consum rapid assay
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
kit histor sold tradit
vet distributor includ henri schein patterson
mwi paid long run although firm requir
increment invest build infrastructur
staff necessari support sale model expect
hold margin profit product
minim risk lose market share competitor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ounlik human healthcar pet health servic
reimburs issu price pressur
associ third-parti payer
oanecdot inform vet suggest
well-integr user-friendli practic manag
softwar help hospit switch stick
product servic
oidexx sale custom support staff garner high
mark provid high-touch servic vet practic
ointern sale account substanti chunk
total revenu dollar strengthen
would feel pain top bottom line
oidexx rapid assay product line vulner
competit pressur vet distributor
firm could see growth area stagnat declin
owhil cardiopet probnp seen impress uptak
thu far key veterinari cardiologist held
enthusiast endors vari
interpret test result across dog breed
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi health strong firm histor
fund expans acquisit primarili
cash gener held virtual long-term debt
last decad unlik rival vca mani year
ago ran financi problem increas
leverag fund substanti expans taken
financi conserv approach consid
firm throw free cash flow percentag sale
low teen manag deploy strateg
acquisit share buyback firm decid
leverag balanc sheet increas debt roughli
time debt/ebitda manag target debt
remain rang intent use
cash fund share repurchas think level debt
manag especi consid
steadi cash flow hinder firm
flexibl choos pursu larger acquisit
opportun expect firm end
medic diagnost technolog idexx
remain vulner potenti technolog disrupt
consum spend consum
less vet traffic reluct spend diagnost
well vet hold purchas
new upgrad equip pressur
livestock poultri product industri may translat
heighten competit less negoti leverag
time regulatori agenc chang
guidelin livestock poultri test protein
market suffer excess suppli prolong low price
rippl effect part busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
share
fund
share
fund
think stewardship exemplari ceo
chairman jonathan ayer step role
lead carrier unit unit technolog
seven year applaud level detail disclosur
compani provid well preponder
outsid eight-memb board includ lead
director like ceo requir report
success plan board least annual
stock vest five year also impress
ayer exchang cash bonu defer
share ayer equiti stake steadili grown
share outstand -- enough sizabl
stake firm futur opinion ayer approach
compens suggest think act
like owner eye toward long term
hand like see director boost stake
put skin game
balanc think manag made wise
capital-alloc decis think rack
admir record acquisit made
number purchas make strateg sens
reason price includ bomm diagnost expand
footprint product anim diagnost across europ
dvminsight bolster telemedicin capabl
radil gain foothold biomed research market
perhap
manag will pass deal
opportun enhanc valu howev
find share repurchas slightli worrisom
mainli stock typic bought premium
valuat
import
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
idexx remain top dog pet diagnost
idexx lab deliv anoth strong quarter wrap
stellar year featur organ growth companion
anim segment substanti boost fair valu
estim per share roughli half
increas driven optimist project
companion anim busi
half fed lower-than-expect new tax rate idexx
come corpor tax cut remain fan idexx
narrow econom moat root cost advantag
intang asset stand behind posit moat
trend rate firm begun build initi network
effect test softwar allow vet
practic understand perform
even without favor tailwind foreign exchang
organ quarterli revenu growth left us impress
consist exce market growth thank
innov coupl high level execut think
recent invest made beef salesforc
bring increas return result
weve bake optimist project next three
year companion anim busi particular
strong placement growth instrument includ catalyst
sedivu key engin on-going stream
increas instal catalyst base
forecast robust mid-teen growth vetlab consum
also expect slight uptick placement
diagnost analyz by-product corpor tax
cut mani vet practic s-corpor enjoy
new effect tax rate anticip
practic invest windfal premium analyz
impress strengthen moat
idexx lab deliv anoth quarter double-digit growth
larg reflect expect top bottom
line slight adjust assumpt
shift valuat slightli rais fair
valu estim per share reflect cash flow realiz
sinc last updat justifi
narrow econom moat thank robust companion
anim revenu growth continu outpac
market firm long impress us abil
innov provid steadi stream new product test
partner close veterinarian custom remain
confid firm posit moat trend howev still
think share expens like reflect take-out
premium follow purchas main refer lab
rival vca mar
despit weaker-than-expect quarterli result
product anim segment deliv
companion anim account
revenu water segment year year
consist favor macroeconom condit
 revenu thank strength refer
lab consum associ benchtop analyz
rapid assay product even hurricane-rel
dampen offic visit quarter materi
hurt third-quart result patient visit
vet revenu consid on-going placement
analyz new test think double-digit growth
consum refer lab sustain
though assum idexx long-term growth
mirror histor growth pet healthcar
particularli pleas see strong price rang
consider higher see
execut well servic market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
seen credibl competitor challeng firm
area although mar opportun
refer lab segment vca
rel poor job remain skeptic new rival
abl success peel client
signific way continu make inroad place
benchtop analyz competit north
american catalyst placement went competit
account third quarter moreov retent
rate companion anim consum remain
rang firm invest beef
 salesforc expect see healthi return
form sticki relationship steadi stream
high-margin consum
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
